Diosmetin suppressed the enhanced pro-inflammatory response and apoptosis via inhibition of the augmentation of NF-κB and P38 kinase activation in a PPAR-γ-dependent manner, facilitating the alleviation of B[a]P-exacerbated H1N1 virus-induced respiratory illness.